Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-02-27 @ 1:08 AM
Study NCT ID:
NCT03117920
Status:
COMPLETED
Last Update Posted:
2023-10-18
First Post:
2017-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
Sponsor:
Minneamrita Therapeutics LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
Minnelide002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None